First Time Loading...

HOOKIPA Pharma Inc
NASDAQ:HOOK

Watchlist Manager
HOOKIPA Pharma Inc Logo
HOOKIPA Pharma Inc
NASDAQ:HOOK
Watchlist
Price: 0.9179 USD 2.1% Market Closed
Updated: May 3, 2024
Section:
 

Wall Street
Price Targets

HOOK Price Targets Summary
HOOKIPA Pharma Inc

Wall Street analysts forecast HOOK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HOOK is 4.42 USD with a low forecast of 3.03 USD and a high forecast of 5.25 USD.

HOOK Lowest Forecast
Wall Street Target
3.03 USD
230% Upside
HOOK Average Forecast
Wall Street Target
4.42 USD
382% Upside
HOOK Highest Forecast
Wall Street Target
5.25 USD
472% Upside
Lowest
Price Target
3.03 USD
230% Upside
Average
Price Target
4.42 USD
382% Upside
Highest
Price Target
5.25 USD
472% Upside
HOOKIPA Pharma Inc Competitors:
Price Targets
B
300289
Beijing Leadman Biochemistry Co Ltd
264% Upside
LYEL
Lyell Immunopharma Inc
169% Upside
688363
Bloomage Biotechnology Corp Ltd
36% Upside
S
688180
Shanghai Junshi Biosciences Co Ltd
29% Upside
B
300289
Beijing Leadman Biochemistry Co Ltd
264% Upside
LYEL
Lyell Immunopharma Inc
169% Upside
688363
Bloomage Biotechnology Corp Ltd
36% Upside
S
688180
Shanghai Junshi Biosciences Co Ltd
29% Upside
TLX
Telix Pharmaceuticals Ltd
5% Upside
i
048530
iNtRON Biotechnology Inc
137% Upside
BIOA B
BioArctic AB
86% Upside
S
SVE
Synthaverse SA
41% Upside

Revenue
Forecast

Revenue Estimate
HOOKIPA Pharma Inc

For the last 5 years the compound annual growth rate for HOOKIPA Pharma Inc's revenue is 21%. The projected CAGR for the next 3 years is -33%.

21%
Past Growth
-33%
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
HOOKIPA Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
HOOKIPA Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
What are analyst estimates?

See Also

Summary
HOOK intrinsic value, competitors valuation, and company profile.
DCF Valuation
HOOK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HOOK stock valuation using valuation multiples.
Wall Street Estimates
HOOK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HOOK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HOOK's stock price target?
Price Target
4.42 USD

According to Wall Street analysts, the average 1-year price target for HOOK is 4.42 USD with a low forecast of 3.03 USD and a high forecast of 5.25 USD.

What is HOOKIPA Pharma Inc's Revenue forecast?
Projected CAGR
-33%

For the last 5 years the compound annual growth rate for HOOKIPA Pharma Inc's revenue is 21%. The projected CAGR for the next 3 years is -33%.

ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.